BackBioLife Sciences Overview

BioLife Sciences Operating Income

BioLife Sciences's operating income is $-320K.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-122.00
↓ 99.79% YoY

As of Feb 28, 2022

Annual Operating Income (TTM)

$-318420.00
↑ 423.48% YoY

Trailing 12 months ending Feb 28, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

BioLife Sciences (BLFE) FAQ

As of the most recent data (February 2022), BLFE shows a operating income of $-320K. That compares with $-61K in the prior-year period — down 423.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLFE's operating income is now $-320K (was $-61K) — a 423.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioLife Sciences is outperforming or lagging.

Tracking BLFE's operating income over time shows whether BioLife Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $-320K That compares with $-61K in the prior-year period — down 423.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has BioLife Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-320K) with ownership activity and broader fundamentals.